NAAG Peptidase Inhibitors (PsychoGenics)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameNAAG Peptidase Inhibitors (PsychoGenics)
Drug Alias NameGCPII Inhibitors (PsychoGenics)N-Acetylaspartylglutamate Peptidase Inhibitors (PsychoGenics)Glutamate Carboxypeptidase II Inhibitors (PsychoGenics)PGI-02776ZJ-11 +[8] 
ClassificationSmall molecules
Mechanisms of ActionProstate-Specific Membrane Antigen inhibitorsNeuroprotectants
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsSchizophreniaPainBrain Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAcenta Discovery
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAcenta DiscoveryPsychoGenics Inc
Active IndicationsN/A
Inactive IndicationsSchizophreniaPainBrain Injuries

Other Information

ATC CodeN/A
Related LinksN/A